CGEN

Compugen Ltd. Press Releases

$8.69
*  
0.11
1.28%
Get CGEN Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading CGEN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Compugen Enters Immuno-Oncology Research Collaboration with Johns Hopkins University
12/18/2014 7:02:00 AM - Business Wire
▲8.49 % Price Change since this news event. The Volume Ratio is 5.31.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Compugen to Present at Oppenheimer 25th Annual Healthcare Conference
12/3/2014 7:01:00 AM - Business Wire
▲28.74 % Price Change since this news event. The Volume Ratio is 1.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Compugen Announces Experimental Confirmation of Additional Methodology for Discovery of Cancer-Related Immune Checkpoints
12/2/2014 7:07:00 AM - Business Wire
▲30.87 % Price Change since this news event. The Volume Ratio is 2.6.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Compugen to Present at Jefferies 2014 Global Healthcare Conference in London
11/12/2014 7:01:00 AM - Business Wire
▲27.05 % Price Change since this news event. The Volume Ratio is 1.73.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Compugen Ltd. Reports Third Quarter 2014 Financial Results
10/29/2014 7:13:00 AM - Business Wire
▲7.02 % Price Change since this news event. The Volume Ratio is 14.47.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Compugen Discloses Successful Validation Results for Novel B7/CD28–like Cancer Immunotherapy Target Candidate
10/27/2014 7:01:00 AM - Business Wire


Compugen Third Quarter 2014 Conference Call Scheduled for Wednesday, October 29, 2014 at 10:00 AM ET
10/22/2014 7:11:00 AM - Business Wire


Compugen Achieves Second Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer
10/14/2014 2:02:00 PM - Business Wire


Compugen Achieves Second Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer
10/14/2014 2:02:00 PM - Business Wire
▲14.19 % Price Change since this news event. The Volume Ratio is 0.96.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Compugen Immune Checkpoint Results Being Presented at Three Scientific Conferences
10/6/2014 7:08:00 AM - Business Wire


Compugen Discloses New Results for Novel Target Candidate for Cancer Immunotherapy
10/1/2014 7:01:00 AM - Business Wire


Compugen Announces Presentations of Results for CGEN-15001 Supporting Immune Tolerance Induction
9/29/2014 7:04:00 AM - Business Wire


Compugen Announces Presentations of Results for CGEN-15001 Supporting Immune Tolerance Induction
9/29/2014 7:04:00 AM - Business Wire